Get the Stockscreener App
2.81
1.81%
+0.05
Poseida Therapeutics Inc Stock (PSTX) Forecast
The Poseida Therapeutics Inc (PSTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.7016, representing a -3.86% decrease from the current price of $2.81. The highest analyst price target is $2.665, and the lowest is $2.7382.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PSTX Price Target
Average 1.6011
(-43.02% Downside)
Is Poseida Therapeutics Inc (PSTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.34 | Neutral |
| STOCH(9,6) | 36.51 | Neutral |
| STOCHRSI(14) | 48.08 | Neutral |
| MACD(12,26) | -0.0175 | Sell |
| ADX(14) | 11.35 | Neutral |
| William %R | -58.00 | Neutral |
| CCI(14) | -28.50 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.7645
Buy
|
2.8036
Buy
|
| MA20 |
2.8723
Sell
|
2.8263
Sell
|
| MA50 |
2.7129
Buy
|
2.8498
Sell
|
| MA100 |
3.0454
Sell
|
2.8943
Sell
|
| MA200 |
2.8064
Buy
|
2.9675
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, PSTX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on PSTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.34 indicates that PSTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 36.51 indicates that PSTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 48.08 indicates that PSTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.35 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -28.5 indicates that PSTX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PSTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Poseida Therapeutics Inc financial reports and earnings history, Poseida Therapeutics Inc (PSTX) stock could reach $11.63 by 2030, $20.43 by 2040 and $14.62 by 2050. See the projected annual prices until 2050 of the Poseida Therapeutics Inc stock below:
- Poseida Therapeutics Inc (PSTX) is expected to reach an average price of $20.86 in 2035, with a high prediction of $20.66 and a low estimate of $20.49. This indicates an $642.33% rise from the last recorded price of $2.81.
- Poseida Therapeutics Inc (PSTX) stock is projected to chart a bullish course in 2040, with an average price target of $18.71, representing an $565.78% surge from its current level. The forecast ranges from a conservative $19.66 to a sky-high $20.43.
- Our analysts predict Poseida Therapeutics Inc (PSTX) to jump 632.29% by 2045, soaring from $20.67 to an average price of $20.58, potentially reaching $20.87. While $20.67 is the low estimate, the potential upside is significant.
- Poseida Therapeutics Inc (PSTX) stock is expected to climb by 2050, reaching an average of $13.79, a $390.85% jump from its current level. However, a wide range of estimates exists, with high and low targets of $14.62 and $13.96, respectively, highlighting the market's uncertainty.
Poseida Therapeutics Inc Stock (PSTX) Year by Year Forecast
Poseida Therapeutics Inc Stock (PSTX) Price Forecast for 2024
Our forecast for PSTX stock price in 2024 now indicates an average price target of $2.5705 with a high forecast of $5.0856 and a low forecast of $0.0555. The average prediction reflects an decrease of -8.52% from the last recorded price of $2.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2024 | $2.6026 | $2.7382 | $2.665 | -7.38% |
| August, 2024 | $0.5401 | $2.9801 | $3.0013 | -80.78% |
| September, 2024 | $1.1676 | $1.2389 | $0.4445 | -58.45% |
| October, 2024 | $0.8395 | $0.2008 | $0.5149 | -70.12% |
| November, 2024 | $1.9771 | $1.0027 | $2.6773 | -29.64% |
| December, 2024 | $2.0746 | $2.3746 | $1.8464 | -26.17% |
Poseida Therapeutics Inc Stock (PSTX) Price Forecast for 2025
Poseida Therapeutics Inc Stock (PSTX) is expected to reach an average price of $1.6216 in 2025, with a high prediction of $2.7023 and a low estimate of $0.5409. This indicates an -42.29% fall from the last recorded price of $2.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.3335 | $1.0277 | $2.7023 | -88.13% |
| February, 2025 | $1.184 | $0.5409 | $1.0296 | -57.86% |
| March, 2025 | $1.1215 | $1.6315 | $1.2628 | -60.09% |
| April, 2025 | $1.8734 | $1.9447 | $1.4534 | -33.33% |
| May, 2025 | $0.051 | $0.561 | $0.5678 | -98.19% |
| June, 2025 | $1.2585 | $1.3953 | $0.7897 | -55.21% |
| July, 2025 | $0.2396 | $1.0204 | $1.1172 | -91.47% |
| August, 2025 | $1.4779 | $1.1562 | $1.4852 | -47.41% |
| September, 2025 | $2.7254 | $1.9023 | $2.3354 | -3.01% |
| October, 2025 | $1.7673 | $2.753 | $2.5786 | -37.11% |
| November, 2025 | $1.8149 | $2.0799 | $1.7155 | -35.41% |
| December, 2025 | $2.2668 | $2.0324 | $1.5736 | -19.33% |
Poseida Therapeutics Inc Stock (PSTX) Price Forecast for 2026
The predicted value for Poseida Therapeutics Inc (PSTX) in 2026 is set at an average of $3.7861. Estimates vary from a peak of $5.3975 to a trough of $2.1746, indicating an +34.74% surge from the present price of $2.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.7243 | $3.6762 | $3.5343 | +32.54% |
| February, 2026 | $4.4518 | $4.2787 | $4.2818 | +58.43% |
| March, 2026 | $3.3494 | $4.4794 | $4.4906 | +19.19% |
| April, 2026 | $3.8113 | $3.5525 | $3.4313 | +35.63% |
| May, 2026 | $5.5188 | $4.8356 | $5.2635 | +96.40% |
| June, 2026 | $5.4063 | $5.5213 | $5.3975 | +92.40% |
| July, 2026 | $4.7882 | $4.8682 | $5.0901 | +70.40% |
| August, 2026 | $4.6157 | $4.5259 | $4.367 | +64.26% |
| September, 2026 | $3.5676 | $2.8689 | $3.4076 | +26.96% |
| October, 2026 | $3.6752 | $3.4108 | $3.202 | +30.79% |
| November, 2026 | $2.6227 | $2.7927 | $3.1095 | -6.67% |
| December, 2026 | $2.1046 | $2.1746 | $2.2571 | -25.10% |
Poseida Therapeutics Inc Stock (PSTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Poseida Therapeutics Inc (PSTX) is $1.6325, with a high forecast of $3.1741 and a low forecast of $0.0909. This indicates an -41.90% decrease from the last price of $2.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4021 | $1.3521 | $1.709 | -85.69% |
| February, 2027 | $0.7704 | $0.5396 | $1.1104 | -72.59% |
| March, 2027 | $2.3384 | $0.366 | $2.3384 | -16.78% |
| April, 2027 | $0.1809 | $0.0909 | $3.1741 | -93.56% |
| May, 2027 | $1.8066 | $0.4535 | $1.1216 | -35.71% |
| June, 2027 | $2.4585 | $2.331 | $2.3297 | -12.51% |
| July, 2027 | $2.536 | $2.2523 | $1.976 | -9.75% |
| August, 2027 | $2.3836 | $2.5836 | $2.3798 | -15.18% |
| September, 2027 | $2.5555 | $2.5379 | $2.4685 | -9.06% |
| October, 2027 | $1.533 | $2.403 | $2.6286 | -45.45% |
| November, 2027 | $2.0205 | $1.8524 | $1.9505 | -28.10% |
| December, 2027 | $1.5724 | $1.7624 | $1.9487 | -44.04% |
Poseida Therapeutics Inc Stock (PSTX) Price Forecast for 2028
In 2028, Poseida Therapeutics Inc (PSTX) is projected to reach an average price of $7.5379, with a high projection of $15.07 and a low estimate of $0.00434. This indicates an +168.25% rise from the last price of $2.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.7099 | $1.5612 | $1.5949 | -39.15% |
| February, 2028 | $0.6975 | $1.3175 | $1.1993 | -75.18% |
| March, 2028 | $0.0406 | $0.1594 | $0.835 | -98.55% |
| April, 2028 | $0.3769 | $0.0238 | $0.3519 | -86.59% |
| May, 2028 | $0.7512 | $0.00434 | $1.0062 | -73.27% |
| June, 2028 | $1.3437 | $0.1337 | $1.4981 | -52.18% |
| July, 2028 | $0.4462 | $0.1649 | $1.4893 | -84.12% |
| August, 2028 | $0.423 | $0.1618 | $0.6842 | -84.95% |
| September, 2028 | $11.91 | $9.96 | $9.0963 | +323.71% |
| October, 2028 | $15.29 | $12.34 | $15.07 | +444.18% |
| November, 2028 | $14.64 | $14.82 | $14.88 | +420.82% |
| December, 2028 | $12.39 | $14.83 | $14.94 | +340.93% |
Poseida Therapeutics Inc Stock (PSTX) Price Forecast for 2029
The 2029 price forecast for Poseida Therapeutics Inc Stock (PSTX) is $11.84 on average, with a high prediction of $13.06 and a low estimate of $10.63. This represents an +321.53% increase from the previous price of $2.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $12.21 | $12.70 | $12.25 | +334.66% |
| February, 2029 | $12.28 | $11.73 | $11.57 | +336.98% |
| March, 2029 | $13.23 | $12.31 | $12.79 | +370.96% |
| April, 2029 | $13.15 | $13.45 | $13.06 | +367.94% |
| May, 2029 | $10.51 | $11.97 | $12.06 | +274.13% |
| June, 2029 | $11.85 | $11.34 | $11.74 | +321.64% |
| July, 2029 | $11.60 | $12.11 | $11.84 | +312.92% |
| August, 2029 | $12.13 | $12.29 | $11.71 | +331.56% |
| September, 2029 | $10.12 | $10.63 | $10.78 | +260.21% |
| October, 2029 | $11.58 | $11.32 | $10.84 | +311.95% |
| November, 2029 | $9.4208 | $10.68 | $10.91 | +235.26% |
| December, 2029 | $10.96 | $10.77 | $10.52 | +289.89% |
Poseida Therapeutics Inc Stock (PSTX) Price Forecast for 2030
Poseida Therapeutics Inc Stock (PSTX) is expected to reach an average price of $11.87 in 2030, with a high forecast of $13.01 and a low forecast of $10.73. This signifies an +322.42% surge from the last price of $2.81.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.93 | $11.33 | $11.63 | +324.54% |
| February, 2030 | $10.83 | $11.84 | $11.78 | +285.58% |
| March, 2030 | $10.70 | $10.96 | $10.65 | +280.77% |
| April, 2030 | $10.59 | $10.73 | $10.37 | +277.04% |
| May, 2030 | $12.20 | $11.09 | $12.01 | +334.11% |
| June, 2030 | $12.74 | $12.71 | $12.57 | +353.51% |
| July, 2030 | $11.42 | $11.95 | $12.69 | +306.32% |
| August, 2030 | $11.69 | $11.51 | $11.31 | +316.10% |
| September, 2030 | $13.22 | $12.67 | $12.96 | +370.38% |
| October, 2030 | $12.57 | $12.98 | $13.01 | +347.38% |
| November, 2030 | $12.08 | $12.16 | $12.52 | +329.77% |
| December, 2030 | $11.72 | $11.68 | $11.59 | +317.13% |
1.81%
1.57%
Cap:
|
Volume (24h):